Differential Inhibition of APOBEC3 DNA‐Mutator Isozymes by Fluoro‐ and Non‐Fluoro‐Substituted 2′‐Deoxyzebularine Embedded in Single‐Stranded DNA
Open Access
- 21 October 2019
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 21 (7), 1028-1035
- https://doi.org/10.1002/cbic.201900505
Abstract
The APOBEC3 (APOBEC3A‐H) enzyme family is part of the human innate immune system that restricts pathogens by scrambling pathogenic single‐stranded DNA (ssDNA) via deamination of cytosines to uracils. However, APOBEC3‐mediated mutagenesis of viral and cancer DNA promotes its evolution, enabling disease progression and development of drug resistance. Therefore, APOBEC3 inhibition offers a new strategy to complement existing anti‐viral and anti‐cancer therapies by making such therapies effective for longer periods of time, thereby preventing the emergence of drug resistance. Here, we have synthesised 2'‐deoxynucleoside forms of several known inhibitors of cytidine deaminase (CDA), incorporated them into oligodeoxynucleotides (oligos) in place of 2'‐deoxycytidine in the preferred substrates of APOBEC3A, APOBEC3B, and APOBEC3G, and evaluated their inhibitory potential against these enzymes. An oligo with 5‐fluoro‐2'‐deoxyzebularine (5FdZ) exhibited a 3.5 times better inhibition constant in comparison with the comparable 2'‐deoxyzebularine (dZ) containing oligo against APOBEC3B. A similar trend of inhibition was observed for wild‐type APOBEC3A. In contrast, use of 5FdZ in an oligo designed for APOBEC3G inhibition resulted in a less potent inhibitor than the dZ‐containing oligo for both APOBEC3GCTD and full‐length wild‐type APOBEC3G.Keywords
Funding Information
- National Institutes of Health (R01-GM110129, R01-GM118000, P01-CA234228)
- Worldwide Cancer Research (16-1197, APC19-0009)
- Palmerston North Medical Research Foundation (RM20532)
- Massey University (MURF2015, MURF RM20734)
- Health Research Council of New Zealand (10/050, 07/050A)
- University of Otago
This publication has 67 references indexed in Scilit:
- Nucleic acid determinants for selective deamination of DNA over RNA by activation-induced deaminaseProceedings of the National Academy of Sciences of the United States of America, 2013
- Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3GNucleic Acids Research, 2012
- AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylationNature Chemical Biology, 2012
- First-In-Class Small Molecule Inhibitors of the Single-Strand DNA Cytosine Deaminase APOBEC3GACS Chemical Biology, 2011
- Local Sequence Targeting in the AID/APOBEC Family Differentially Impacts Retroviral Restriction and Antibody DiversificationJournal of Biological Chemistry, 2010
- Determinants of sequence-specificity within human AID and APOBEC3GDNA Repair, 2010
- APOBEC3 proteins mediate the clearance of foreign DNA from human cellsNature Structural & Molecular Biology, 2010
- Herpes Simplex Virus-1 DNA Primase: A Remarkably Inaccurate yet Selective PolymeraseBiochemistry, 2009
- A Portable Hot Spot Recognition Loop Transfers Sequence Preferences from APOBEC Family Members to Activation-induced Cytidine DeaminasePublished by Elsevier BV ,2009
- Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3GThe EMBO Journal, 2009